Gene Expression Profiling Identified TP53MutPIK3CAWild As a Potential Biomarker for Patients with Triple-Negative Breast Cancer Treated with Immune Checkpoint Inhibitors.
Oncology Letters（2020）
Key words
triple-negative breast cancer,immune checkpoint inhibitors,biomarker,TP53(Mut)PIK3CA(Wild)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined